Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,900
Employees9,900
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,900
Employees9,900

ELAN Key Statistics

Market cap
12.10B
Market cap12.10B
Price-Earnings ratio
-49.52
Price-Earnings ratio-49.52
Dividend yield
Dividend yield
Average volume
5.68M
Average volume5.68M
High today
$24.49
High today$24.49
Low today
$22.90
Low today$22.90
Open price
$23.74
Open price$23.74
Volume
10.24M
Volume10.24M
52 Week high
$27.72
52 Week high$27.72
52 Week low
$13.16
52 Week low$13.16

Stock Snapshot

With a market cap of 12.1B, Elanco(ELAN) trades at $23.82. The stock has a price-to-earnings ratio of -49.52.

As of 2026-06-21, Elanco(ELAN) stock has fluctuated between $22.90 and $24.49. The current price stands at $23.82, placing the stock +4.0% above today's low and -2.7% off the high.

The Elanco(ELAN)'s current trading volume is 10.24M, compared to an average daily volume of 5.68M.

In the last year, Elanco(ELAN) shares hit a 52-week high of $27.72 and a 52-week low of $13.16.

In the last year, Elanco(ELAN) shares hit a 52-week high of $27.72 and a 52-week low of $13.16.

ELAN News

Simply Wall St 19h
Does Elanco’s New Canine Vaccine and Venture Arm Reframe Its Innovation Story For ELAN Investors?

Elanco Animal Health recently received USDA approval for TruCan Ultra Lyme-L4, the first 1/2 mL canine combination vaccine protecting against both Lyme disease...

Does Elanco’s New Canine Vaccine and Venture Arm Reframe Its Innovation Story For ELAN Investors?
TipRanks 3d
Elanco price target raised to $32 from $31 at TD Cowen

TD Cowen analyst Steve Scala raised the firm’s price target on Elanco (ELAN) to $32 from $31 and keeps a Buy rating on the shares. The firm said seven potential...

TipRanks 3d
Elanco to launch Elanco Ventures for animal health innovation

Elanco (ELAN) Animal Health plans to establish Elanco Ventures, a dedicated corporate venture capital platform designed to support, invest and advance innovatio...

Analyst ratings

94%

of 16 ratings
Buy
93.8%
Hold
6.3%
Sell
0%

More ELAN News

TipRanks 5d
Neurizon Secures Long-Term Elanco Supply Deal for Lead ALS Drug NUZ-001

Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.